Notes From the 2010 Annual Meeting of the Korean Society of Thoracic Radiology: Pure Ground-Glass Nodules, Part-Solid Nodules and Lung Adenocarcinomas

Journal of Thoracic Imaging

Volumn 26, Issue 3, 2011, Pages W99-W104

  Lee, Hyun Ju ^a   Ahn, Myeong Im ^a   Kim, Yoon Kyung ^a   Seon, Hyun Ju ^a   Goo, Jin Mo ^a   Im, Jung Gi ^a   Park, Chan Sup ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FLUORODEOXYGLUCOSE; PACLITAXEL;

ADULT; ASPIRATION BIOPSY; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SIZE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; COUGHING; DELETION MUTANT; DIAGNOSTIC ACCURACY; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUOROSCOPY; FOLLOW UP; GROUND GLASS NODULE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG BIOPSY; LUNG HEMORRHAGE; LUNG LOBECTOMY; LUNG METASTASIS; LUNG NODULE; METASTASIS; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS BIOPSY; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; THORAX PAIN; THORAX RADIOGRAPHY; TUMOR VOLUME; VIDEO ASSISTED THORACOSCOPIC SURGERY; WEDGE RESECTION;

ADENOCARCINOMA; ADULT; DEMOCRATIC PEOPLE'S REPUBLIC OF KOREA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTORY, 21ST CENTURY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; RADIOGRAPHY, THORACIC; SOLITARY PULMONARY NODULE;

EID: 80051482685     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0b013e318219d910     Document Type: Article

References (14)

1. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005;23:3279-3287
2. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244-285
3. Shimizu K, Ikeda N, Tsuboi M, et al. Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT. Lung Cancer. 2006;51:173-179
4. Kim TJ, Lee JH, Lee CT, et al. Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol. 2008;190:234-239
5. Carter D, Vazquez M, Flieder DB, et al. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer. 2007;56:193-199
6. Kim TJ, Goo JM, Lee KW, et al. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule. Lung Cancer. 2009;64:171-178
7. Chung JH, Choi G, Jheon S, et al. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground glass opacity differentiates multicentric origin from intrapulmonary spread. J Thorac Oncol. 2009;4:1490-1495
8. Vazquez M, Carter D, Brambilla E, et al. Solitary and multiple resected adenocarcinomasafter CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer. 2009;64:148-154
9. Park JH, Lee KS, Kim JH, et al. Malignant pure pulmonary ground-glass opacity nodules: prognostic implications. Korean J Radiol. 2009;10:12-20
10. Kim HK, Choi YS, Kim K, et al. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer. J Thorac Oncol. 2009;4:1242-1246
11. Yatabe Y, Takahashi T, Mitsudomi T. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Cancer Res. 2008;68:2106-2111
12. Martin P, Kelly CM, Carney D. Epidermal growth factor receptor-targeted agents for lung cancer. Cancer Control. 2006;13:129-140
13. Sharma SV, Bell DW, Settleman J, et al. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer. 2007;7:169-181
14. Jackman DM, Miller VA, Cioffredi LA, et al. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials. Clin Cancer Res. 2009;15:5267-5273